- P-ISSN 1010-0695
- E-ISSN 2288-3339
Objective:To construct a comprehensive understanding of thepharmaceutical efficacies of ginseng, then build a basis for a research strategy for development of Korean ginseng as a globally-competitive medical product. Methods:Surveying literature, we found 1690 ginseng-focused papers in Pub-Med. Analysis of was done of number of reports according to date, nation, components of Panax ginseng, research methods, and effects of ginseng. Results:The main countries contributing toginseng research are China, Korea, Japan and America. Recently, ginseng-related studies have been increasing, and individual compounds from ginseng or its products rather than ginseng itself are subjects for study. Anti-cancer associated or neuroprotective effects showed priority in therapeutic efficacy. Panax ginseng was the focus of around 60% of all ginseng-related studies, but only 22% of them were done in Korea. Conclusion:This review will help Korean doctors or scientists to systematically understand ginseng as a powerfulh- erbal medicine, and to develop Korean ginseng as a globally competitive drug in world markets.
1. Radad K, Gille G, Liu L, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci. 2006;100:175-186.
2. Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician. 2003;68:1539-1542.
3. Zeng XL, Tu ZG. Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721 Ai Zheng. 2004;23:879-284.
4. Cui Y, Shu XO, Gao YT, Cai H, Tao MH, Zheng W. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 2006;163: 645-653.
5. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic admin- istration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differ- entially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997;30:181-190.
6. LinksJi YC, Kim YB, Park SW, Hwang SN, Min BK, Hong HJ, Kwon JT, Suk JS. Neuro- protective effect of ginseng total saponins in experimental traumatic brain injury. J Korean Med Sci. 2005;20:291-296.
7. Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther. 2003;2:247-267.
8. Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, Kim DH. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull. 2005;28:652-256.
9. Zhang YG, Liu TP. Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ische- mia in rats. Zhongguo Yao Li Xue Bao. 1996; 17:44-8.
10. Martinez-Mir I, Rubio E, Morales-Olivas FJ, Palop-Larrea V. Transient ischemic attack secondary to hypertensive crisis related to Panax ginseng. Ann Pharmacother. 2004;38: 1970.
11. Huong NT, Matsumoto K, Watanabe H. The antistress effect of majonoside-R2, a major saponin component of Vietnamese ginseng: neuronal mechanisms of action.Methods Find Exp Clin Pharmacol. 1998;20:65-76.
12. Huong NT, Murakami Y, Tohda M, Watanabe H, Matsumoto K. Social isolation stress- induced oxidative damage in mouse brain and its modulation by majonoside-R2, a Vietna- mese ginseng saponin. Biol Pharm Bull. 2005 ;28:1389-1393.
13. 2005 건강기능식품 품목별 통계, 한국 인삼제품협회, 2006.
14. 손창규, 유사라. 한의계의 한국인삼 세계화 노력제고를 위한 국내외의 시장 분석 연구, J Korean Oriental Med. 2007;28:100-107.
15. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci. 2001;16:S28-37.
16. Coleman CI, Hebert JH, Reddy P. The effects of Panax ginseng on quality of life.J Clin Pharm Ther. 2003;28:5-15.
17. Shim JY, Han Y, Ahn JY, Yun YS, Song JY. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide- treated normal and tumor bearing mice. Int J Immunopathol Pharmacol. 2007;20:487-297.
18. Wurz GT, Marchisano-Karpman C, DeGregorio MW. Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene- induced mammary tumors in mice. Oncol Res. 2006;16:251-260.
19. Banz WJ, Iqbal MJ, Bollaert M, Chickris N, James B, Higginbotham DA, Peterson R, Murphy L. Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine. 2007;14:681-689.
20. Lee TK, Johnke RM, Allison RR, O’Brien KF, Dobbs LJ Jr. Radioprotective potential of ginseng. Mutagenesis. 2005;20:237-243.
21. Liou CJ, Huang WC, Tseng J. Long-term oral administration of ginseng extract modulates humoral immune response and spleen cell functions. Am J Chin Med. 2005;33:651-61
22. 서정철, 허정걸, 한상원, 아경림, 변준석, 김명수, 하일도, 임강현. 한국인과 중국인에서 체온에 대한 고려삼과 화기삼의 영향. 동의생리병리학회지. 2003;17:837-841.
23. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002;25:323-344.
24. Yap KY, Chan SY, Weng Chan Y, Sing Lim C. Overview on the analytical tools for quality control of natural product-based supplements: a case study of ginseng.Assay Drug Dev Technol. 2005;3:683-699.
25. Kim J, Jo BH, Lee KL, Yoon ES, Ryu GH, Chung KW. Identification of new microsatellite markers in Panax ginseng. Mol Cells. 2007; 24:60-68.